HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Clinical trials for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Off-the-Shelf' cell therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests an experimental cell therapy called GT719 for adults with relapsed or refractory B-cell blood cancers (lymphoma and leukemia) that have not responded to standard treatments. The therapy uses donor-derived immune cells designed to attack cancer cells c…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New cell therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis study tests an experimental treatment called GT719 for adults with certain blood cancers (B-cell lymphoma or leukemia) that have not responded to standard therapy or have returned. The treatment is a type of cell therapy that targets a protein called CD19 on cancer cells. Th…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: PHASE1, PHASE2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 11, 2026 20:40 UTC